IO Biotech, Inc. (IOBTQ) Interest & Investment Income (2022 - 2025)

IO Biotech (IOBTQ) has 4 years of Interest & Investment Income data on file, last reported at $255000.0 in Q3 2025.

• Quarterly Interest & Investment Income fell 76.12% year-over-year to $255000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.7 million (down 71.81% YoY) and the FY2024 annual result came in at $4.7 million, down 19.78% from the prior year.
• Interest & Investment Income eased to $255000.0 in Q3 2025, from $285000.0 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $1.9 million in Q4 2023 to a low of $15000.0 in Q1 2022.
• A 4-year average of $864200.0 and a median of $780000.0 in 2022 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2023 — Interest & Investment Income surged 6753.33% — and 2025, when it plunged 78.26%.
• Tracing IOBTQ's Interest & Investment Income over 4 years: stood at $780000.0 in 2022, then jumped by 149.87% to $1.9 million in 2023, then slumped by 62.96% to $722000.0 in 2024, then sank by 64.68% to $255000.0 in 2025.
• The last three Interest & Investment Income figures came in at $255000.0 (Q3 2025), $285000.0 (Q2 2025), and $414000.0 (Q1 2025), per Business Quant data.